Cancer Gene Therapy Market Aims for a Staggering US$ 5.3 Bil

From 2022 to 2032, the global cancer gene therapy market is anticipated to expand at a 10.1% compound annual growth rate (CAGR) and reach US$ 2 billion in 2022. The oncolytic virotherapy segment held 49.3% of the global cancer gene therapy market in 2021, according to Future Market Insights (FMI). This market is pro...

Related Keywords

Canada , Delaware , United States , Germany , China , New York , America , Bristol Myers Squibb , Oncolytic Virotherapy , Market Insights Inc , Astrazeneca Plc , Novartis , Biocancell Ltd , Life Science Inc , Genelux Corporation , Greater New York Chamber , Merck Kgaa , Cell Genesys Inc , Amgen Inc , Genvec Inc , Consumer Technology , Effrx Pharmaceuticals , Advantagene Inc , Crinetics Pharmaceuticals Inc , Merck Kga , Clinical Research Laboratory , Service Provider , Future Market Insights , Sample Copy , North America , East Asia , Carisma Therapeutics , Companies Profiled , Cancer Gene Therapy Market , Market Segments Covered , Cancer Gene Therapy Industry , Middle East , Tailored Insights , Customize Your Report , Maximum Impact , Market Insights , Stevie Award , Sales Enquiries ,